Management of renal cell carcinoma in transplant kidney: a systematic review and meta-analysis.

Fabio Crocerossa,Riccardo Autorino,Ithaar Derweesh,Umberto Carbonara,Francesco Cantiello,Rocco Damiano,Jose Rubio-Briones,Morgan Roupret,Alberto Breda,Alessandro Volpe,M Carmen Mir

Minerva urology and nephrology（2023）

引用 3|浏览16

暂无评分

摘要

PN and TA might be offered as a nephron-sparing treatment in patients with T1a gRCC. There is no significant difference between these options and GN in terms of oncological outcomes and complications. PN and TA offer similar functional outcomes and graft preservation. PN for T1b gRCC seems feasible and safe, but its validity should be considered unverified.

查看译文

关键词

renal cell carcinoma,transplant kidney,systematic review,meta-analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要